1. Home
  2. CRCT vs ESPR Comparison

CRCT vs ESPR Comparison

Compare CRCT & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$4.33

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.09

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
ESPR
Founded
1969
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
898.5M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
CRCT
ESPR
Price
$4.33
$3.09
Analyst Decision
Strong Sell
Buy
Analyst Count
3
6
Target Price
$3.60
$6.67
AVG Volume (30 Days)
478.9K
5.5M
Earning Date
03-03-2026
03-03-2026
Dividend Yield
21.16%
N/A
EPS Growth
27.98
N/A
EPS
0.37
N/A
Revenue
$714,492,000.00
$303,802,000.00
Revenue This Year
$1.06
$26.11
Revenue Next Year
N/A
N/A
P/E Ratio
$12.15
N/A
Revenue Growth
N/A
2.83
52 Week Low
$3.94
$0.69
52 Week High
$7.33
$4.18

Technical Indicators

Market Signals
Indicator
CRCT
ESPR
Relative Strength Index (RSI) 28.72 32.93
Support Level $4.74 $3.00
Resistance Level $4.97 $4.18
Average True Range (ATR) 0.18 0.23
MACD -0.06 -0.11
Stochastic Oscillator 11.25 4.26

Price Performance

Historical Comparison
CRCT
ESPR

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: